Teva Wants Ex-Exec DQ'd As Expert In Namenda Buyers' Suit

By Rachel Graf (July 3, 2017, 1:36 PM EDT) -- Teva Pharmaceuticals USA has urged a New York federal judge to disqualify one of its former executives as an expert in an antitrust suit alleging Forest Laboratories LLC blocked generic alternatives to its Namenda Alzheimer's treatment, saying the former employee has been exposed to confidential information related to Teva....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!